HEMOCHRON SIGNATURE INSTRUMENT / ACT-LR ASSAY
Report
- Report Number
- 2248721-2009-00042
- Event Type
- Other
- Date Received
- February 10, 2009
- Report Date
- February 10, 2009
- Manufacturer
- INTERNATIONAL TECHNIDYNE CORP.
- Product Code
- JBP
- PMA / PMN Number
- K960749
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- OH, US
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
Narratives
(B)(4). DUE TO RECENT RECEIPT OF INFO BY ITC CLARIFYING REPORTING RULES WHERE BOTH MULTIPLE PTS AND MULTIPLE DEVICES ARE INVOLVED. IN ACCORDANCE WITH THAT INFO, THIS F/U REPORT CLARIFIES THE PT - ADVERSE EVENT RELATIONSHIP AS OPPOSED TO PRIOR REPORTS WHICH NOTED THE DEVICE - ADVERSE EVENT RELATIONSHIP. IN A TELECONFERENCE WITH THE MEDICAL DIRECTOR ON (B)(6) 2008, THE MEDICAL DIRECTOR CONCLUDED THAT FACILITY WILL NOT RETURN PRODUCT FOR ITC EVAL AS: CORRELATION STUDIES PERFORMED BY THE FACILITY SHOW ACCEPTABLE PERFORMANCE OF THE SUBJECT HEMOCHRON SYSTEM. HEMOCHRON SYSTEMS IN PLACE AT OTHER AREAS OF THE HOSPITAL ARE PERFORMING WELL. FACILITY BELIEVES THE SUBJECT HEMOCHRON SYSTEM IS OPERATING CORRECTLY. THE SUBJECT HEMOCHRON SYSTEM CONTINUES TO BE USED WITHOUT ISSUE IN FACILITY. WHILE NOT PROVEN TO BE DIRECTLY CORRELATED TO THE SUBJECT EVENTS, PPT DRUG TREATMENT THERAPY FOR NEONATES ON ECMO WITH DIAPHRAGMATIC HERNIAS HAS BEEN ALTERED. FACILITY HAS BEEN REQUESTED TO PROVIDE IN-HOUSE CORRELATION STUDY DATA TO MFR.
OVER APPROX 12 MONTHS PERIOD, 6 PTS IN FACILITY NEONATE UNIT EXPERIENCED CRANIAL BLEED FOR UNDETERMINED REASONS. PTS ARE CATEGORIZED BY FACILITY AS HIGH-RISK, ON ECMO, WITH DIAPHRAGMATIC HERNIAS. FACILITY INVESTIGATION CONCLUDED HEMOCHRON SIGNATURE/ACT-LR SYSTEM NOT CAUSAL AND HAS ALTERED DRUG TREATMENT THERAPY PRACTICES. THIS REPORT IS FOR PT 6 OF 6.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | HEMOCHRON SIGNATURE INSTRUMENT / ACT-LR ASSAY | HEMOCHRON SIGNATURE ACT-LR | JBP | INTERNATIONAL TECHNIDYNE CORP. | HE-SIG | ASSAY/UNAVAILABLE |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | UNK | Other |